3-Methylsalicylic acid structure
|
Common Name | 3-Methylsalicylic acid | ||
|---|---|---|---|---|
| CAS Number | 83-40-9 | Molecular Weight | 152.147 | |
| Density | 1.3±0.1 g/cm3 | Boiling Point | 293.2±28.0 °C at 760 mmHg | |
| Molecular Formula | C8H8O3 | Melting Point | 98-100 °C(lit.) | |
| MSDS | Chinese USA | Flash Point | 145.4±20.5 °C | |
| Symbol |
GHS05, GHS07 |
Signal Word | Danger | |
Use of 3-Methylsalicylic acid3-Methylsalicylic acid is a salicylic acid derivative compound with marked fibrinolytic activity in human plasma by activating its fibrinolytic system. |
| Name | 3-Methylsalicylic acid |
|---|---|
| Synonym | More Synonyms |
| Description | 3-Methylsalicylic acid is a salicylic acid derivative compound with marked fibrinolytic activity in human plasma by activating its fibrinolytic system. |
|---|---|
| Related Catalog |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 293.2±28.0 °C at 760 mmHg |
| Melting Point | 98-100 °C(lit.) |
| Molecular Formula | C8H8O3 |
| Molecular Weight | 152.147 |
| Flash Point | 145.4±20.5 °C |
| Exact Mass | 152.047348 |
| PSA | 57.53000 |
| LogP | 2.52 |
| Vapour Pressure | 0.0±0.6 mmHg at 25°C |
| Index of Refraction | 1.600 |
| Storage condition | -20?C Freezer |
| Water Solubility | 1.5 g/L (20 ºC) |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
MUTATION DATA
|
| Symbol |
GHS05, GHS07 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H302-H315-H318-H335 |
| Precautionary Statements | P261-P280-P305 + P351 + P338 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Faceshields;Gloves |
| Hazard Codes | Xn:Harmful |
| Risk Phrases | R22;R41 |
| Safety Phrases | S26-S36/39-S22 |
| RIDADR | UN 2811 |
| WGK Germany | 3 |
| RTECS | BZ4385000 |
| HS Code | 2918290000 |
| Precursor 9 | |
|---|---|
| DownStream 10 | |
| HS Code | 2918290000 |
|---|---|
| Summary | HS: 2918290000 other carboxylic acids with phenol function but without other oxygen function, their anhydrides, halides, peroxides, peroxyacids and their derivatives Tax rebate rate:9.0% Supervision conditions:AB(certificate of inspection for goods inward,certificate of inspection for goods outward) VAT:17.0% MFN tariff:6.5% General tariff:30.0% |
|
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
J. Med. Chem. 54 , 591-602, (2011) Fragment-based lead design (FBLD) has been used to identify new metal-binding groups for metalloenzyme inhibitors. When screened at 1 mM, a chelator fragment library (CFL-1.1) of 96 compounds produced... |
|
|
Ion-pairing reversed-phase liquid chromatography fractionation in combination with isotope labeling reversed-phase liquid chromatography–mass spectrometry for comprehensive metabolome profiling
J. Chromatogr. A. 1218(23) , 3689-94, (2011) We report a novel two-dimensional (2D) separation strategy aimed at improving the detectability of liquid chromatography mass spectrometry (LC–MS) for metabolome analysis. It is based on the use of io... |
|
|
In vitro inhibition of salicylic acid derivatives on human cytosolic carbonic anhydrase isozymes I and II.
Bioorg. Med. Chem. 16 , 9101-5, (2008) The inhibition of two human cytosolic carbonic anhydrase (hCA, EC 4.2.1.1) isozymes, hCA I and II, with a series of salicylic acid derivatives was investigated by using the esterase method with 4-nitr... |
| Cresotic acid |
| 2-carboxy-6-methylphenol |
| o-cresotic acid |
| o-cresotinic |
| Hydroxytoluic |
| EINECS 209-447-8 |
| 2-Hydroxy-3-methyl-benzoic acid |
| 3-Methylsalicylic acid |
| Benzoic acid, 2-hydroxy-3-methyl- |
| 2-ANISIC ACID |
| 3-methyl salicylic acid |
| 3-MS |
| 2-Hydroxy-3-methylbenzoic acid |
| cresotinicacid |
| MFCD00002431 |